Ticker Scorecard - AIM Basics Company: AIM ImmunoTech Inc. IPO Date: August 1, 1996 Sector: Healthcare Industry: Biotech Market Cap: $12.44M Activated in VL: True Average Daily Range Avg Daily Range: $0.11 | 3.44% Avg Daily Range (30 D): $0.01 | 3.42% Avg Daily Range (90 D): $0.01 | 4.64% Institutional Daily Volume Avg Daily Volume: .3M Avg Daily Volume (30 D): .57M Avg Daily Volume (90 D): .43M Trade Size Avg Trade Size (Sh.): 401 Avg Trade Size (Sh.) (30 D): 841 Avg Trade Size (Sh.) (90 D): 839 Institutional Trades Total Inst.Trades: 20 Avg Inst. Trade: $1.17M Avg Inst. Trade (30 D): $M Avg Inst. Trade (90 D): $M Avg Inst. Trade Volume: .41M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $.79M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 312.22K     News Dec 14, 2024 @ 9:54 PM Kellner Group Denounces False Rumors About AIM Sho... Source: N/A Dec 12, 2024 @ 2:00 PM AIM ImmunoTech Expands Patent Portfolio with New N... Source: Aim Immunotech Inc. Sep 27, 2024 @ 12:00 PM AIM ImmunoTech to Participate in Virtual Investor ... Source: Aim Immunotech Inc. Aug 16, 2024 @ 11:00 AM AIM ImmunoTech Reports Second Quarter 2024 Financi... Source: Aim Immunotech Inc. Jul 3, 2024 @ 12:57 PM AIM ImmunoTech Announces Release of the Next CEO C... Source: Aim Immunotech Inc. Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.47 $-.06 $-.03 Diluted EPS $-.47 $-.06 $-.03 Revenue $ .19M $ .04M $ .05M Gross Profit $ $ $ Net Income / Loss $ -23.93M $ -3.7M $ -1.84M Operating Income / Loss $ -27.92M $ -4.49M $ -3.69M Cost of Revenue $ $ $ Net Cash Flow $ -14.35M $ -2.64M $ .26M PE Ratio     Splits Jun 11, 2019:   44:1 Aug 29, 2016:   12:1